- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Next-week expectancy is positive at 57.22% based on similar historical setup states.
THC
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Tenet Healthcare Corporation · Healthcare · Medical Care Facilities
Latest close
233.2 USD
19.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 17.6% above the Trend Line and sits at 85.4% of its 52-week range. The latest completed week returned 19.6%, after a 23.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is mixed with 37/100 conviction, while the latest news-sentiment score is 61/100.
Setup score
65
out of 100
Latest Close
233.2 USD
24 Jul 2026
1W Return
19.6%
latest completed week
4W Return
23.4%
short-term follow-through
12W Return
27.2%
quarterly tape
Trend Breadth
67.3%
35 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
19.6%
Latest completed week; four-week move 23.4%.
Indicator stack
37/74
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 57.22%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
37/100 conviction; expected move 15.4%.
News sentiment
61/100
81 relevant articles in the latest sentiment read.
Event risk
28 Jul
Latest stored earnings date was 28 Jul 2026.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 17.6% above the Trend Line and sits at 85.4% of its 52-week range. The latest completed week returned 19.6%, after a 23.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2012-week average 0.25
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 23.4% over four weeks, 27.2% over 12 weeks, and 52.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year35
Trend breadth67.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.63Latest activity-pressure read.
Pressure change164.1%Four-week change in activity pressure.
Leadership9.74Latest relative-leadership reading.
RS change201.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 94%
Model confidence 94%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength98/100Blend of value, momentum, and quality. Underlying universe rank 3; rank 1 is best.
Value91/100Relative valuation strength. Underlying universe rank 10; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework93/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.0x Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 7.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 14.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 26.9% Gross profit retained from each unit of revenue.
- Operating margin
- 19.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 23.0% Free cash flow generated from revenue.
- Return on invested capital
- 21.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 5.4% Latest one-year revenue growth.
- EPS growth
- 51.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 48.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 6.9% Net share repurchases relative to market value.
- Shareholder yield
- 6.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
THC shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 0.64, expected move of 15.4%, and Sharemaestro trend signal inactive.
Conviction37/100
Expected move15.4%
Put/call volume0.64
Insider activity13 / 7
13 acquisitions and 7 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment61/100
Weighted news tone is neutral across 81 relevant articles.
37 positive · 41 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings28 JulLatest stored earnings date was 28 Jul 2026.
Options expected move15.4%Nearest-chain priced movement where available.
52-week drawdown-5.7%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+19.6%Week of 24 Jul.
Worst week-12.0%Week of 20 Mar.
Latest week+19.6%Week of 24 Jul.
Shape of recent returns
Strong gains7
Modest gains8
Flat weeks0
Modest losses5
Sharp losses6
Recent vol7.7%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank2 / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Care Facilities
4-week rank3 / 45
Group average1.8%
Trend breadth71.1%
Trend71.1%active weekly trend signals
MD86.7%positive activity pressure
RS53.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis13/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 1/12.
Activity pressure 0.20; 2 reversal markers Next-Week ExpectancyPositive 57.22%Next-week expectancy is positive with a 57.22% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors90/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Cornerstone Growth rank 18; Buyback Yield rank 8 SVQF93/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 72.0 of 1013 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options47/100THC shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 0.64, expected move of 15.4%, and Sharemaestro trend signal inactive.
Mixed · Options-market disagreement · Expected move 15.4% Sentiment61/100Weighted news tone is neutral across 81 relevant articles.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue? Insiders13 / 713 acquisitions and 7 disposals in the latest 180-day insider tape.
Earnings28 JulLatest stored earnings date was 28 Jul 2026.
Research flow1 items0 recent research articles and 1 Market Watch posts are available.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 233.2 USD | 19.6% | 198.3 USD | 145.3 USD | 0.63 | 9.74 | 9.0M | Off |
| 17 Jul 2026 | 194.9 USD | -4.6% | 197.2 USD | 144.3 USD | 0.20 | -8.37 | 8.1M | Off |
| 10 Jul 2026 | 204.2 USD | 0.3% | 197.2 USD | 143.5 USD | -0.25 | -5.59 | 4.4M | Off |
| 3 Jul 2026 | 203.7 USD | 7.8% | 197.1 USD | 142.7 USD | -0.64 | -4.64 | 5.5M | Off |
| 26 Jun 2026 | 189.0 USD | 9.5% | 197.3 USD | 141.9 USD | -0.98 | -9.64 | 5.5M | Off |
| 19 Jun 2026 | 172.6 USD | -1.2% | 198.2 USD | 141.3 USD | -1.22 | -19.59 | 6.7M | Off |
| 12 Jun 2026 | 174.7 USD | 7.8% | 198.9 USD | 140.6 USD | -1.18 | -18.16 | 6.7M | Off |
| 5 Jun 2026 | 162.1 USD | -7.6% | 199.5 USD | 140.0 USD | -1.04 | -23.85 | 8.5M | Off |
| 29 May 2026 | 175.3 USD | 0.9% | 200.9 USD | 139.5 USD | -0.91 | -20.06 | 5.3M | Off |
| 22 May 2026 | 173.8 USD | -11.6% | 202.0 USD | 138.8 USD | -0.71 | -19.91 | 7.6M | Off |
| 15 May 2026 | 196.7 USD | 3.3% | 203.2 USD | 138.2 USD | -0.60 | -8.89 | 6.5M | Off |
| 8 May 2026 | 190.4 USD | 3.9% | 203.3 USD | 137.4 USD | -0.58 | -11.70 | 8.1M | Off |
| 1 May 2026 | 183.3 USD | 1.4% | 203.3 USD | 136.6 USD | -0.55 | -13.05 | 11.4M | Off |
| 24 Apr 2026 | 180.8 USD | -8.1% | 203.9 USD | 135.9 USD | -0.64 | -13.47 | 8.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.